The present invention provides a method of diagnosing the presence or severity of liver fibrosis in an individual by detecting 2-macroglobulin (2-MG) in a sample from the individual; detecting hyaluronic acid (HA) in a sample from the individual; detecting tissue inhibitor of metalloproteinases-1 (TIMP-1) in a sample from the individual; and diagnosing the presence or severity of liver fibrosis in the individual based on the presence or level of 2-MG, HA and TIMP-1.